Anagenics Ltd has released a press release.
Cleansing Notice and Appendix 3B
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Anagenics
- Cellmid Share Purchase Plan
- Cellmid Share Placement Raises $9M
- Cellmid updates on distribution of evolis
- Cellmid to commence selling of evolis into chinese market
- Cellmid secures bloomingdales usa partnership for evolis
Later from Anagenics
- Preliminary Final Report
- Evolis USA Distribution Update
- Cellmid Share Purchase Plan Completion
- Lead Antibody Effective in Rare Chronic Kidney Disease
- Change of Registry Address: Automic P/L - Sydney Office
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics